help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ouyang, H.
Right arrow Articles by Tsao, M.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ouyang, H.
Right arrow Articles by Tsao, M.-S.
(American Journal of Pathology. 2000;157:1623-1631.)
© 2000 American Society for Investigative Pathology

Regular Articles

Immortal Human Pancreatic Duct Epithelial Cell Lines with Near Normal Genotype and Phenotype

Hong Ouyang*, Lun-jun Mou*, Catherine Luk{dagger}, Ni Liu*, Jana Karaskova*, Jeremy Squire*{dagger}{ddagger} and Ming-Sound Tsao*{dagger}{ddagger}

From the Ontario Cancer Institute*
and the Department of Laboratory Medicine and Pathobiology,{dagger}
University Health Network-Princess Margaret Hospital, Toronto; and the Department of Medical Biophysics,{ddagger}
University of Toronto, Toronto, Ontario, Canada

Immortal epithelial cell lines were previously established after transduction of the HPV16-E6E7 genes into primary cultures of normal pancreatic duct epithelial cells. Single clones were isolated that demonstrated near normal genotype and phenotype. The proliferation of HPDE6-E6E7c7 and c11 cells is anchorage-dependent, and they were nontumorigenic in SCID mice. The cell lines demonstrated many phenotypes of normal pancreatic duct epithelium, including mRNA expression of carbonic anhydrase II, MUC-1, and cytokeratins 7, 8, 18, and 19. These cells have normal Ki-ras, p53, c-myc, and p16INK4A genotypes. Cytogenetic studies demonstrated losses of 3p, 10p12, and 13q14, the latter included the Rb1 gene. The wild-type p53 protein was detectable at very low levels consistent with the presence of E6 gene product, and the lack of functional p53 pathway was confirmed by the inability for {gamma}-irradiation to up-regulate p53 and p21waf1/cip1 protein. The p110/Rb protein level was also not detectable consistent with the expression of E7 protein and haploid loss of Rb1 gene. Despite this, the proliferation of both c7 and c11 cells were markedly inhibited by transforming growth factor-ß1. This was associated with up-regulation of p21cip1/waf1 but not p27kip1. Further studies showed that p130/Rb2 and cyclin D3 were expressed, suggesting that p130/Rb2 may have partially assumed the maintenance of G1 cell cycle checkpoint regulation. These results indicate that except for the loss of p53 functional pathway, the two clones of HPDE6-E6E7 cells demonstrated a near normal genotype and phenotype of pancreatic duct epithelial cells. These cell lines will be useful for future studies on the molecular basis of pancreatic duct cell carcinogenesis and islet cell differentiation.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. L. Warner, B. J. Stephens, S. Nwokenkwo, G. Hostetter, A. Sugeng, M. Hidalgo, J. M. Trent, H. Han, and D. D. Von Hoff
Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
Clin. Cancer Res., November 1, 2009; 15(21): 6519 - 6528.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Geismann, M. Morscheck, D. Koch, F. Bergmann, H. Ungefroren, A. Arlt, M.-S. Tsao, M. G. Bachem, P. Altevogt, B. Sipos, et al.
Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor {beta}1- and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer
Cancer Res., May 15, 2009; 69(10): 4517 - 4526.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Moriyama, K. Ohuchida, K. Mizumoto, J. Yu, N. Sato, T. Nabae, S. Takahata, H. Toma, E. Nagai, and M. Tanaka
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
Mol. Cancer Ther., May 1, 2009; 8(5): 1067 - 1074.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
R. P. Sahu and S. K. Srivastava
The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl Isothiocyanate
J Natl Cancer Inst, February 4, 2009; 101(3): 176 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Pan, T. Arumugam, T. Yamamoto, P. A. Levin, V. Ramachandran, B. Ji, G. Lopez-Berestein, P. E. Vivas-Mejia, A. K. Sood, D. J. McConkey, et al.
Nuclear Factor-{kappa}B p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
Clin. Cancer Res., December 15, 2008; 14(24): 8143 - 8151.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Jones, X. Zhang, D. W. Parsons, J. C.-H. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, et al.
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Science, September 26, 2008; 321(5897): 1801 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
B. Stephens, H. Han, G. Hostetter, M. J. Demeure, and D. D. Von Hoff
Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells
Mol. Cancer Ther., January 1, 2008; 7(1): 202 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Li, Y. Zhang, Z. Liu, U. Bharadwaj, H. Wang, X. Wang, S. Zhang, J. P. Liuzzi, S.-M. Chang, R. J. Cousins, et al.
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression
PNAS, November 20, 2007; 104(47): 18636 - 18641.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Ji, F. C. Mei, J. Xie, and X. Cheng
Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells
J. Biol. Chem., May 11, 2007; 282(19): 14048 - 14055.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Hayes, P. E. Carrigan, and L. J. Miller
Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas
Cancer Res., March 1, 2007; 67(5): 2072 - 2080.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. M. Campbell, A. L. Groehler, K. M. Lee, M. M. Ouellette, V. Khazak, and C. J. Der
K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase Signaling
Cancer Res., March 1, 2007; 67(5): 2098 - 2106.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Wang, H. Han, and D. D. Von Hoff
Identification of an Agent Selectively Targeting DPC4 (Deleted in Pancreatic Cancer Locus 4)-Deficient Pancreatic Cancer Cells
Cancer Res., October 1, 2006; 66(19): 9722 - 9730.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. L. Warner, R. M. Munoz, P. Stafford, E. Koller, L. H. Hurley, D. D. Von Hoff, and H. Han
Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells.
Mol. Cancer Ther., October 1, 2006; 5(10): 2450 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Ohuchida, K. Mizumoto, S. Ohhashi, H. Yamaguchi, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
S100A11, A Putative Tumor Suppressor Gene, Is Overexpressed in Pancreatic Carcinogenesis.
Clin. Cancer Res., September 15, 2006; 12(18): 5417 - 5422.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. T. Nawrocki, J. S. Carew, M. S. Pino, R. A. Highshaw, R. H.I. Andtbacka, K. Dunner Jr., A. Pal, W. G. Bornmann, P. J. Chiao, P. Huang, et al.
Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
Cancer Res., April 1, 2006; 66(7): 3773 - 3781.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Hayes, P. E. Carrigan, A. M. Beck, and L. J. Miller
Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma.
Cancer Res., April 1, 2006; 66(7): 3819 - 3827.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. T. Nawrocki, J. S. Carew, K. Dunner Jr., L. H. Boise, P. J. Chiao, P. Huang, J. L. Abbruzzese, and D. J. McConkey
Bortezomib Inhibits PKR-Like Endoplasmic Reticulum (ER) Kinase and Induces Apoptosis via ER Stress in Human Pancreatic Cancer Cells
Cancer Res., December 15, 2005; 65(24): 11510 - 11519.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Qian, J. Niu, M. Li, P. J. Chiao, and M.-S. Tsao
In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K-ras Oncogenic Activation in Pancreatic Carcinogenesis
Cancer Res., June 15, 2005; 65(12): 5045 - 5053.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Marchesi, P. Monti, B. E. Leone, A. Zerbi, A. Vecchi, L. Piemonti, A. Mantovani, and P. Allavena
Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4
Cancer Res., November 15, 2004; 64(22): 8420 - 8427.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Gasa, C. Mrejen, N. Leachman, M. Otten, M. Barnes, J. Wang, S. Chakrabarti, R. Mirmira, and M. German
Proendocrine genes coordinate the pancreatic islet differentiation program in vitro
PNAS, September 7, 2004; 101(36): 13245 - 13250.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
P. J. Gray Jr, D. J. Bearss, H. Han, R. Nagle, M.-S. Tsao, N. Dean, and D. D. Von Hoff
Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer
Mol. Cancer Ther., May 1, 2004; 3(5): 641 - 646.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. M. Al-Aynati, N. Radulovich, R. H. Riddell, and M.-S. Tsao
Epithelial-Cadherin and {beta}-Catenin Expression Changes in Pancreatic Intraepithelial Neoplasia
Clin. Cancer Res., February 15, 2004; 10(4): 1235 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. E. Hansel, A. Rahman, S. Wehner, V. Herzog, C. J. Yeo, and A. Maitra
Increased Expression and Processing of the Alzheimer Amyloid Precursor Protein in Pancreatic Cancer May Influence Cellular Proliferation
Cancer Res., November 1, 2003; 63(21): 7032 - 7037.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Matsubayashi, N. Sato, N. Fukushima, C. J. Yeo, K. M. Walter, K. Brune, F. Sahin, R. H. Hruban, and M. Goggins
Methylation of Cyclin D2 Is Observed Frequently in Pancreatic Cancer but Is Also an Age-related Phenomenon in Gastrointestinal Tissues
Clin. Cancer Res., April 1, 2003; 9(4): 1446 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
B. Terris, E. Blaveri, T. Crnogorac-Jurcevic, M. Jones, E. Missiaglia, P. Ruszniewski, A. Sauvanet, and N. R. Lemoine
Characterization of Gene Expression Profiles in Intraductal Papillary-Mucinous Tumors of the Pancreas
Am. J. Pathol., May 1, 2002; 160(5): 1745 - 1754.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.